Half-year report · Q2
2931.TEDINET S100U6LW
Period2024-01-01 → 2024-06-30
Filed2024-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.6bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥46.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥22.8bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | ¥348m | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | −¥760m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | ¥309m | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥1.4bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥639m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥476m | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥618m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥267m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.7bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥914m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥235m | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | −¥913m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥70.3bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥59.6bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥60.8bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.0bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥39.4bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥31.3bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.2bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥21.7bn | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥19.1bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.8bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥18.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.7bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥16.2bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥16m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥658m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥500m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥361m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥646m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥351m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥507m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥5.8bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.2bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2.02 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-22.76 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.88 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 44.5% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.9% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.7% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥811m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥306m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥306m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥251m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥22.0bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥22.0bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥1.7bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥242m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥23.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥23.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥0 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥862m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥432m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥724m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥189m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-06-30 | ¥101m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 659
| Item | Context | Value | Unit |
|---|---|---|---|
| Distribution | Prior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember | 1877000000 | JPY |
| Distribution | Prior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Distribution | Prior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Distribution | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1877000000 | JPY |
| Distribution | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Distribution | Prior1YTDDuration | 1877000000 | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember | 549000000 | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 549000000 | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Original equipment manufacturing material overseas | Prior1YTDDuration | 549000000 | JPY |
| Others | Prior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember | 1493000000 | JPY |
| Others | Prior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember | 901000000 | JPY |
| Others | Prior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember | 1392000000 | JPY |
| Others | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 3787000000 | JPY |
| Others | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Others | Prior1YTDDuration | 3787000000 | JPY |
| Revenue from contracts with customers | Prior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember | 20510000000 | JPY |
| Revenue from contracts with customers | Prior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember | 901000000 | JPY |
| Revenue from contracts with customers | Prior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember | 1392000000 | JPY |
| Revenue from contracts with customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 22805000000 | JPY |
| Revenue from contracts with customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenue from contracts with customers | Prior1YTDDuration | 22805000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember | 20510000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember | 901000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember | 1392000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 22805000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 22805000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember | 20510000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember | 901000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember | 1392000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 22805000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 22805000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember | 724000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember | -432000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E27054-000OthersBusinessReportableSegmentsMember | -189000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 101000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -862000000 | JPY |
| Operating income | Prior1YTDDuration | -760000000 | JPY |
| Direct sales | CurrentYTDDuration_jpcrp040300-q2r_E27054-000HealthCareBusinessReportableSegmentsMember | 16495000000 | JPY |
| Direct sales | CurrentYTDDuration_jpcrp040300-q2r_E27054-000BiofuelBusinessReportableSegmentsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |